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Abstract: Staphylococcus epidermidis strains are diverse in their pathogenicity. Some are 
invasive virulent strains causing serious nosocomial infections; some are skin commensals 
with a low virulence. The discrimination of them is of great clinical significance. To analyze 
the implication of different factors in virulence, phenotypical methods were applied. 
Comparative assessment of the enzymatic activity of nosocomial and commensal strains of  
S. epidermidis was performed: alkaline phosphatase (PHA), beta-glucosidase  (LAC ), 
arginine dehydrolase (ARG), urease (URE), maltosidase (PAM), N-acetylglutamic acid 
hydrolase (FPY), N-acetylglucosaminehydrolase (FGA ) were studied. Differences were 
found in the urease activity, i.e. 93% and 77% of commensal and nosocomial strains, 
respectively, were positive. 
 
In sheep blood agar, the difference was more significant – only 16.7% of commensal strains 
demonstrated the haemolytic activity, but 52.4% of nosocomial strains occurred to be 
haemolytic. 
 
Keywords:  Nosocomial strains, Commensals, Gram-positive microorganisms, Virulence, 
Staphylococcus epidermidis. 
 
Introduction 
Staphylococcus epidermidis is the leading representative of the diverse group of   
coagulase-negative staphylococci (CNS). It is a commensal bacterium of the human body and 
is referred to  as a normal inhabitant of the healthy skin and mucous membranes. As a 
commensal microorganism, it has a low pathogenic potential [1, 4, 18], but during the last 
decades, like Staphylococcus aureus, it has evolved to become a highly adaptable human 
pathogen. Since the early 1980s, it has emerged as an important nosocomial pathogen and is 
among the most frequent health-care associated pathogens, featuring prominently among 
blood culture isolates and especially causing infections associated with implanted devices 
such as intravascular catheters and deep-seated prosthetic implants [2, 6, 7, 14, 18].   INT. J. BIOAUTOMATION, 2010, 14(3), 179-186 
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However, S. epidermidis infections preferentially affect immunocompromized patients, or in 
other words, in order to realize the potential pathogenicity and change from normal skin 
commensal to a pathogenic microorganism, some host predisposition is required. 
 
The virulence factors of coagulase-negative staphylococci, including S. epidermidis, are yet 
not well defined.  
 
Several attempts have been made to investigate this problem. Evidence indicates that the main 
factor, which determines the virulence of S. epidermidis, is the production of extracellular 
polysaccharides – slime, which results in the formation of a biofilm. It permits 
microorganisms to adhere to plastic surfaces, protects from phagocytosis and antimicrobials 
[3, 5, 12, 16]. 
 
From other virulence factors, some secreted proteins may be mentioned such as hemolysins, 
toxins – haemolytic peptide δ toxin and different enzymes – lipases, proteases, lecithinase, 
elastase, etc [8, 10, 11, 13, 15, 19]. However, no particular virulence markers have been 
determined. 
 
S. epidermidis is the most frequent gram-positive bacterium, which can be isolated from 
different clinical samples. Its ubiquitous prevalence as a commensal bacterium on the skin 
and mucous membranes makes it very difficult to decide, whether an isolated microorganism 
is the causative agent of a clinical process or an innocuous representative of normal microbial 
flora [17]. 
 
So, one of the major challenges of a daily diagnostic work is to distinguish clinically 
significant invasive strains from contaminants. The finding of markers allowing the rapid 
differentiation between virulent and non-virulent microorganisms would be of great clinical 
value. 
 
The objective of the present work was to search for S. epidermidis virulence factors, applying 
different phenotypical and genotypical methods, and to evaluate the studied features as 
possible criteria for the discrimination between virulent nosocomial and non-virulent 
contaminant strains. In the current article, the results of the investigated phenotypical features 
of S. epidermidis are presented. Our attention was focused mainly on the exoenzyme and 
hemolysin production. 
 
Materials and methods 
The study was carried out during 2008-2009 at the Hospital of Traumatology and 
Orthopaedics, Riga, Latvia. Samples from patients with hospital-acquired purulent surgical 
infections were examined. Most of the cultures were isolated from wounds, the skin, 
abscesses, indwelling artificial devices and joints using blood agar. S. epidermidis isolates 
were prospectively collected under the guidance of a clinical infectologist to choose clinically 
significant strains. The isolated microorganisms were resistant to several antimicrobials. 
Control cultures were obtained after the collection of samples from anterior nares of healthy 
volunteers, who had no contact with the hospital environment. The initial samples were 
cultured on mannitol-salt agar plates. After 24 hours, two colonies of each donor were 
randomly selected. Standard laboratory techniques were used to identify coagulase-negative 
staphylococci and to exclude S. aureus. The automated BBL Crystal gram-positive ID System 
(Becton, Dickinson) was used for identification of isolates on the species level. The resistance 
to a panel of antimicrobials was tested by the disk diffusion method according to     INT. J. BIOAUTOMATION, 2010, 14(3), 179-186 
 
  181
CLSI standards [21, 22]. The following enzyme activities were studied: alkaline phosphatase 
(PHA), beta-glucosidase (LAC), arginine dehydrolase (ARG), urease (URE), maltosidase 
(PAM), N-acetylglutamic acid hydrolase (FPY), N-acetylglucosaminehydrolase (FGA). The 
haemolytic activity of microorganisms was tested on plates with 5% sheep or 5% human 
blood agar. 
 
The CSI reference strain S. epidermidis ATCC 12228 was used as the control. 
 
Results 
Cultures  
A  total of 437  cultures from clinical samples were isolated, from them 380 (87%) were   
gram-positive microorganisms, and 57 (13%) gram-negative. So, the leading nosocomial flora 
occurred to be gram-positive. 
 
The analysis of gram-positive microorganisms revealed the prevalence of staphylococci, both 
coagulase-positive and coagulase-negative staphylococci (CNS) (Table 1).  
 
Table 1. Isolated gram-positive microorganisms 
Microorganisms  Number of cultures 
(abs., % of gram-positive) (n = 380) 
S. aureus  168 cultures – 44.2% 
CNS spp.  146 cultures – 38.4% 
Enterococcus  34 cultures – 9.0% 
Others  32 cultures – 8.4% 
 
From coagulase-negative staphylococci, 91.3% belonged to the novobiocin sensitive group, 
the other 8.7% were novobiocin resistant. 
 
The results of species identification of the isolated CNS are presented in Table 2. 
 
Table 2. Species identification of isolated CNS 
Species  Number of cultures (abs., %) 
(n = 104) 
S. epidermidis  53 (51.0%) 
S. haemolyticus  27 (26.0%) 
S. hominis  4 (3.8%) 
S. capitis  4 (3.8%) 
S. warneri  4 (3.8%) 
S. simulans  3 (2.9%) 
S. saprophyticus  7 (6.8%) 
S. cohnii  2 (1.9%) 
 
S. epidermidis was the most frequently isolated species. The leading role of this species is 
confirmed by many researchers [1, 9, 18]. S. epidermidis was followed by S. haemolyticus.   INT. J. BIOAUTOMATION, 2010, 14(3), 179-186 
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The remaining species were distributed among S. hominis, S. capitis, S. warneri, S. simulans, 
S. saprophyticus (Table 3). 
 
The species ratios of CNS isolated at our hospital during the last 5 years were rather stable.  
 
Table 3. Isolated CNS species during 2005-2009 
Species  Year 2009  Year 2008  Year 2007  Year 2006  Year 2005 
S. epidermidis  51.0%  56.0% 56.0% 55.0% 64.0% 
S. haemolyticus  26.0%  14.2% 14.2% 14.1% 11.2% 
S. hominis  3.8% 10.2% 12.2%  7.9%  8.4% 
S. capitis  3.8%  4.1% 2.1% 6.7%  10.5% 
S. warneri  3.8%  2.9% 0.7% 5.6% 3.5% 
S. simulans  2.9%  2.9% 3.5% 2.2% 0.7% 
S. saprophyticus  6.7%  5.0% 5.7% 9.0% 2.8% 
 
Enzymatic activity  
Staphylococci are known for their pronounced phenotypical variability [8, 16, 18].   
The heterogenous gene expression is typically observed in nosocomial microbial strains due 
to the adaptation to the changing environment. So, we performed a comparative assessment of 
the enzymatic activity of nosocomial and commensal strains of S. epidermidis. Two groups of 
enzymes were studied in respect to variable activities: alkaline phosphatase (PHA),   
beta-glucosidase (LAC), arginine dehydrolase (ARG), and in respect to stable activities: 
urease, (URE), maltosidase (PAM), N-acetylglutamic acid hydrolase (FPY),   
N-acetylglucosaminehydrolase (FGA). The results are presented in Table 4. 
 
Table 4. Enzymatic activity of commensal and nosocomial S. epidermidis strains 
Commensal strains (n = 83)  Nosocomial strains (n = 30) 
Enzymes  Positive 
reaction 
Negative 
reaction 
Positive 
reaction 
Negative 
reaction 
Alkaline phosphatase 
(PHO)  40 (48.0%)  43 (52.0%)  15 (50.0%)  15 (50.0%) 
Urease (URE)  77 (93.0%)  6 (7.0%)  23 (77.0%)  7 (23.0%) 
Arginine dehydrolase 
(ARG)  80 (96.4%)  3 (3.6%)  30 (100%)  0 (0%) 
Maltosidase (PAM)  18 (22.0%)  65 (78.0%)  6 (20.0%)  24 (80.0%) 
N-acetylglycosamine 
hydrolase (FGA)  0 (0%)  83 (100%)  0 (0%)  30 (100%) 
L-piroglutamic acid 
hydrolase (FPY)  0 (0%)  83 (100%)  0 (0%)  30 (100%) 
ß-glucosidase  (LAC)  78 (94.0%)  5 (6.0%)  28 (93.0%)  2 (7.0%) 
 
It can be seen from Table 4 that differences in enzyme production between commensal 
isolates and nosocomial isolates of S. epidermidis were observed only in the case of urea 
utilization. Other enzymatic activities did not differ significantly.   INT. J. BIOAUTOMATION, 2010, 14(3), 179-186 
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Haemolytic activity  
The results of the investigation of the haemolytic activity of different strains of S. epidermidis 
were as follows. 71 (85.5%) of the 83 commensal cultures produced hemolysins in human 
blood agar, while in the nosocomial group, the activity was lower, i.e. 63.3%. In sheep blood 
agar, the difference was opposite and more significant, i.e. only 16.7% of 54 commensal 
strains demonstrated the haemolytic activity, but from nosocomial strains, 52.4% occurred to 
be haemolytic. 
 
Slime production  
According to our previously published data, slime production in nosocomial S. epidermidis 
strains was more active than in commensal strains, i.e. 33.6% and 10.2% respectively [23]. 
The trypan blue test was used in these experiments. For confirmation of these results, at the 
present moment, the work is continued applying genotypical methods – detection of icaA and 
aap genes. 
 
Discussion  
The study of the pathogenicity and virulence factors of coagulase-negative staphylococci was 
carried out by several groups of researchers. The difference was not found in production of 
exoenzymes – lecithinase, lipase, DNAse, TNA-se and phenol-soluble modulins in virulent 
and non-virulent strains [9, 15, 19]. So, a reliable phenotypical test as a marker for the 
detection of the aggressivity of clinical strains of S. epidermidis is not yet found. 
 
We propose the following method for the detection of the virulence of the isolated   
S. epidermidis strain in clinical practice: at first phenotypical features must be evaluated, then 
urease-negative organisms with the haemolytic activity in sheep blood agar as more 
perspective must be studied for biofilm formation. The problem is that many hospital 
diagnostic laboratories frustrate the precise recognition of the diverse microbial nature of 
CNS infections. We suggest that rapid automated biochemical identification of CNS, together 
with conventional methods, is necessary prior to genotypical studies. 
 
Conclusions 
1.  Rapid automated biochemical identification of coagulase-negative staphylococci is the 
first necessary step for the detection of their virulence. 
2.  Urease activity in nosocomial strains is lowered in comparison with the case of 
commensal strains. 
3.  The haemolytic activity of nosocomial strains in sheep blood agar is more than three times 
higher than in commensal strains. In human blood agar, differences were not found. 
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